Sumitomo Pharma Co., Ltd. (DNPUF)
14.36
-2.38
(-14.19%)
USD |
OTCM |
Dec 12, 09:30
Sumitomo Pharma Profit Margin (Quarterly): 73.58% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | -1.05% |
| Nxera Pharma Co., Ltd. | -24.76% |
| PeptiDream Inc. | -25.38% |
| Stemcell Holdings, Inc. | -- |
| Healios KK | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 86.44% |
| Return on Assets | 19.72% |
| Return on Invested Capital | 30.31% |
| Gross Profit Margin (Quarterly) | 61.73% |
| Operating Margin (Quarterly) | 19.54% |
| Return on Net Operating Assets | 25.50% |